News

How Ozempic’s Maker Lost Its Shine After Creating a Wonder Drug
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...
Covington Ramps Up Novo Nordisk's Legal Blitz For Ozempic Trademark Cases
The drugmaker is a large and consistent client for Covington. The law firm has represented Novo Nordisk in several dozen ...
Ozempic Maker Novo Nordisk Terminates Multiple Pipeline Programs, Faces Investor Lawsuit Over GLP-1 Market Misrepresentation
Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...
Novo Nordisk: This Won't Last
Novo Nordisk remains the GLP-1 leader with over 65% market share. Read an in-depth BVO stock analysis and why we rate it as a ...
Investor's Business Daily on MSN2d
Novo Nordisk Slumps As 'Unlawful' Knockoffs Pressure Wegovy, Ozempic
Novo Nordisk stock slumped Wednesday after saying it expects compounded versions to undercut sales of its obesity drug, ...
Novo Nordisk expands lawsuits against weight-loss drug compounders
Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of ...
24/7 Wall St.10d
Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...
Ozempic maker Novo Nordisk has its worst day since Black Monday
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Futurism on MSN1d
The Creator of Ozempic Is in Terrible Trouble
While its customers are losing weight, Novo Nordisk, the creator of the mega-hit drug Ozempic, is shedding loads of market ...